These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 520175

  • 1. [Improvement of growth-hormone stimulation with l-dopa/l-carbidopa by simultaneous administration of propranolol (author's transl)].
    Schönberger W, Grimm W, Ziegler R.
    Dtsch Med Wochenschr; 1979 Dec 21; 104(51):1811-3. PubMed ID: 520175
    [Abstract] [Full Text] [Related]

  • 2. The effect of nacom (L-dopa and L-carbidopa) on growth hormone secretion in 75 patients with short stature.
    Schönberger W, Grimm W, Ziegler R.
    Eur J Pediatr; 1977 Dec 30; 127(1):15-9. PubMed ID: 606555
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous stimulation of growth hormone, adrenocorticotropin and cortisol with L-dopa/L-carbidopa and propranolol in children of short stature.
    Philippi H, Pohlenz J, Grimm W, Koffler T, Schönberger W.
    Acta Paediatr; 2000 Apr 30; 89(4):442-6. PubMed ID: 10830457
    [Abstract] [Full Text] [Related]

  • 4. [HGH secretion after oral application of L-dopa and L-carbidopa (author's transl)].
    Schönberger W, Ziegler R, Brodt B, Grimm W.
    Eur J Pediatr; 1976 Jun 08; 122(3):195-200. PubMed ID: 1278188
    [Abstract] [Full Text] [Related]

  • 5. [Stimulation of the secretion of somatotropin by administration of Nacom (L-dopa and L-carbidopa) in ambulatory patients with retarded growth].
    Schönberger W, Grimm W, Ziegler R, Brodt B.
    Monatsschr Kinderheilkd (1902); 1977 May 08; 125(5):485-7. PubMed ID: 876212
    [No Abstract] [Full Text] [Related]

  • 6. On the mechanism of hyperglycemia and stimulation of growth hormone secretion by L-dopa.
    Hampshire J, Moraru E, Altszuler N.
    Pharmacology; 1978 May 08; 17(3):138-48. PubMed ID: 704657
    [Abstract] [Full Text] [Related]

  • 7. The effect of L-dopa with and without decarboxylase inhibitor on growth hormone secretion in children with short stature.
    Fevang FO, Stoa RF, Thorsen T, Aarskog D.
    Acta Paediatr Scand; 1977 Jan 08; 66(1):81-4. PubMed ID: 831384
    [Abstract] [Full Text] [Related]

  • 8. [HGH response to dihydroxyphenylalanine (L-dopa) (author's transl)].
    Del Valle Núñez CJ, García Guerrero M, García De Pesquera F, Pérez Bryan J.
    An Esp Pediatr; 1976 Jan 08; 9(2):174-9. PubMed ID: 937869
    [Abstract] [Full Text] [Related]

  • 9. [Attempt at potentiation of the action of L-dopa on the secretion of growth hormone by benserazide, disulfiram and propranolol].
    Rochiccioli P, Enjaume P, Dutau G, Ribot C, Augier D.
    Arch Fr Pediatr; 1976 Jan 08; 33(1):55-66. PubMed ID: 985031
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone response in very short children.
    Palayew K, Crock P, Pianosi P, Coates A, Weitzner G, Schiffrin A.
    Clin Invest Med; 1991 Aug 08; 14(4):331-7. PubMed ID: 1782731
    [Abstract] [Full Text] [Related]

  • 11. [Stimulation of growth hormone (STH) in the outpatient clinic using L-Dopa plus carbidopa and physical loading].
    Amendt P, Rohde W.
    Kinderarztl Prax; 1979 Jul 08; 47(7):362-7. PubMed ID: 480794
    [No Abstract] [Full Text] [Related]

  • 12. [Combination of L-dopa, desipramine, and a decarboxylase inhibitor in the treatment of depression (author's transl)].
    Eisenring JJ, Dick P, Tissot R, Yanniotis G.
    Psychopharmacologia; 1973 Oct 23; 33(1):95-101. PubMed ID: 4769026
    [No Abstract] [Full Text] [Related]

  • 13. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F, Picotti GB, Massara F, Molinatti GM, Mantegazza P, Müller EE.
    J Clin Endocrinol Metab; 1978 Sep 23; 47(3):647-52. PubMed ID: 263317
    [Abstract] [Full Text] [Related]

  • 14. Letter: Enhancement of levodopa-induced growth-hormone stimulation by propranolol.
    Camanni F, Massara F.
    Lancet; 1974 May 11; 1(7863):942. PubMed ID: 4133478
    [No Abstract] [Full Text] [Related]

  • 15. [Results of the treatment of Parkinson's diseases with carbidopa and L-Dopa].
    Cáceres AF.
    Rev Fac Cienc Med Cordoba; 1974 May 11; 32(2):161-74. PubMed ID: 4619691
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)].
    Hanzal F.
    MMW Munch Med Wochenschr; 1976 May 14; 118(20):653-6. PubMed ID: 818540
    [Abstract] [Full Text] [Related]

  • 17. Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease.
    Bell RD, Carruth A, Rosenberg RN, Boyar RM.
    J Clin Endocrinol Metab; 1978 Oct 14; 47(4):807-11. PubMed ID: 45469
    [Abstract] [Full Text] [Related]

  • 18. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM, Miller S, Gunder M.
    Acta Derm Venereol; 1983 Oct 14; 63(2):97-101. PubMed ID: 6189350
    [Abstract] [Full Text] [Related]

  • 19. [Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
    Nurzia A, Vacca U, Pirro R, Cerone G.
    Clin Ter; 1975 Aug 15; 74(3):265-70. PubMed ID: 1227747
    [No Abstract] [Full Text] [Related]

  • 20. Role of peripheral adrenoreceptors and vasopressin in the suppression of plasma renin activity by L-dopa in carbidopa-treated dogs.
    Blair ML, Reid IA, Keil LC, Ganong WF.
    J Pharmacol Exp Ther; 1979 Sep 15; 210(3):368-72. PubMed ID: 480187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.